The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...

Researchers at the University of Veterinary Medicine Vienna are reporting that Goffin's cockatoos (Cacatua goffiniana) engage ...

The New York State Department of Health is raising awareness about the Ebola virus following a Health Alert Network issued by ...

The January 2025 issue of Nature includes an article on the NIH-funded dGTEx project, titled, "The Human and Non-human ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

A bill before the legislature would ensure a peaceful, pain-free life for primates no longer needed for medical testing, ...

University of Wisconsin researchers and collaborators recently published a feasibility study that focuses on limiting fetal growth restriction in nonhuman primates through nanoparticle injections of ...

New three-month data from a study of non-human primates underpins the biotech firm's decision to amend the small interfering RNA program.

LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Voyager Therapeutics (VYGR) has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 amyotrophic ...

A woman has been indicted in a Laredo federal court for the smuggling attempt of five spider monkeys, according to court ...